ArticleCureus2025
HELLP (Hemolysis, Elevated Liver Enzymes, and Low Platelets) Syndrome Without Hypertension Associated With Fetal Loss in the Second Trimester of Pregnancy: A Report of a Rare Case.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome without hypertension presenting in the second trimester of pregnancy is an extremely rare obstetric complication, associated with significantly increased rates of maternal and perinatal morbidity and mortality. This case report concerns a 24-year-old multigravida woman in her 25th week of gestation, who presented to the Emergency Department of the General Hospital of Trikala, Greece, with symptoms of general malaise and clinical signs indicative of preterm labor. Following ultrasonographic confirmation of absent fetal cardiac activity, the patient was admitted to the maternity ward, where she delivered vaginally. Awaiting delivery, clinical and laboratory investigations (combined with the subsequent exclusion of other pregnancy-related pathological conditions characterized by atypical thrombocytopenia and microangiopathic hemolytic anemia) led to the definitive diagnosis of HELLP syndrome without hypertension. In this case report, we describe the rare manifestation of HELLP syndrome without hypertension during the second trimester of pregnancy, a presentation associated with fetal demise. Following the case description, a brief literature review is provided, focusing on the pathogenesis, diagnosis, and management of this rare clinical entity, whose timely and accurate treatment can significantly improve outcomes for both the mother and the fetus or neonate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.